Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.
While America's attention remains fixated on the steel, aluminum, and automotive sectors affected by President Trump's sweeping tariffs, a more insidious threat looms on the horizon: digital tariffs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback